Tissue Engineered Solutions for Intracardiac Septal Defects: A La.pdf (602.44 kB)
0/0

Tissue Engineered Solutions for Intracardiac Septal Defects: A Large Step Forward in an Unmet Clinical Need.

Download (602.44 kB)
report
posted on 22.11.2019 by Aamir Hameed, Garry P. Duffy, Babar Hasan, Saulat Husnain Fatimi

Congenital heart disease (CHD) is the occurrence of an anomaly in the heart structure during fetal development. The incidence of CHD is estimated to be 8 per 1000 live births in the United States, 6.9 per 1000 live births in Europe and 9.3 per 1000 live births in Asia.1 CHD varies in severity and timing of emergence of symptoms, hence they differ in ways of management.

Logo branding

Categories

Keyword(s)

History

Comments

This is a non-final version of an article published in final form in http://journals.lww.com/annalsofsurgery/toc/2017/02000

Published Citation

Hameed A, Duffy GP, Hasan B, Fatini SH. Tissue Engineered Solutions for Intracardiac Septal Defects: A Large Step Forward in an Unmet Clinical Need. Annals of Surgery. 2017;265(2)e11-e12.

Publication Date

01/02/2017

Publisher

Lippincott Williams & Wilkins

Exports

Logo branding

Categories

Keyword(s)

Exports